Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Sell
15,709
-1,726
-10% -$158K 0.02% 173
2026
Q1
$1.79M Sell
17,435
-10,350
-37% -$1.17M 0.03% 163
2025
Q4
$3.49M Sell
27,785
-203
-0.7% -$25.9K 0.05% 121
2025
Q3
$3.73M Buy
27,988
+15
+0.1% +$1.97K 0.06% 114
2025
Q2
$3.8M Sell
27,973
-146
-0.5% -$19.3K 0.07% 110
2025
Q1
$3.73M Sell
28,119
-965
-3% -$123K 0.07% 111
2024
Q4
$3.29M Buy
29,084
+408
+1% +$47.1K 0.06% 111
2024
Q3
$3.27M Sell
28,676
-257
-0.9% -$28.2K 0.07% 112
2024
Q2
$3.01M Sell
28,933
-1,688
-6% -$179K 0.06% 107
2024
Q1
$3.48M Sell
30,621
-70,808
-70% -$8.12M 0.08% 108
2023
Q4
$11.2M Buy
+101,429
New +$10.1M 0.29% 69

Other funds holding ABT

Sapient Capital's ABT Position: Q2 2026 in Review

Sapient Capital reduced its Abbott (ABT) stake by 9.9% in Q2 2026, selling an estimated $158K and leaving 15,709 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #173.

Sapient Capital first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.2M in Q4 2023. 520 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Sapient Capital held 15,709 shares of Abbott worth $1.43M as of Q2 2026.
  • Sapient Capital sold 1,726 Abbott shares in Q2 2026, an estimated $158K.
  • Abbott made up 0.02% of Sapient Capital's portfolio in Q2 2026, its #173 holding.
  • Sapient Capital first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's Abbott position peaked at $11.2M in Q4 2023.
  • 520 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.